Funded by Merz Pharmaceuticals and developed in partnership with Stroke Alliance for Europe, the educational platform Life with Spasticity was developed to provide information and support for stroke survivors who experience post-stroke spasticity.
“In addition to providing emotional support and motivation for stroke survivors, the ‘Life With Spasticity’ website also offers a meaningful overview of post-stroke spasticity treatments and rehabilitation processes. We want to ensure that stroke survivors and their caregivers receive accurate and accessible information about the treatment options available to them,” says Jon Barrick, president of SAFE, in a media release. “We believe that everyone who has had a stroke should have the opportunity to make the best possible recovery.”
“Merz continues to seek out and incorporate direct patient input for our ongoing spasticity and post-stroke awareness initiatives, which we believe should be shaped according to patients’ real needs from the very beginning,” explains Dr Yannick Grosskreutz, Executive Director and Head of Global Marketing Neurotoxins for Merz Pharmaceuticals, in the release. “The ‘Life With Spasticity’ website is just one example of how we are putting that concept into practice.”
Before launching the website, Merz teamed with a patient advisory board of European stroke survivors and their caregivers living with spasticity, as well as SAFE board members, to test the site, receive feedback regarding the site’s overall accessibility, and to generate content for the FAQs section.
In the coming months, the release adds, Merz will continue to work closely with the patient ambassadors and with SAFE to regularly update the FAQs section.
[Source(s): Merz Pharmaceuticals, Business Wire]
